Trials / Completed
CompletedNCT03646682
Pharmakokinetik of Caffeine in Epiretinal Membranes After Oral Intake: a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Vienna Institute for Research in Ocular Surgery · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Caffeine concentrations in the vitreous Body and exzised epiretinal membranes are measured by gas-chromatography/mass spectrometry.
Detailed description
Caffeine concentrations in the vitreous Body and exzised epiretinal membranes are measured by gas-chromatography/mass spectrometry. One hour before surgery patients in the caffeine Group will receive 180mg of caffeine. in all patients vitrectomy with Membrane Peeling will be performed, due to epiretinal membranes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | vitrectomy with membrane peeling | during vitrectomy with membrane peeling a prob of the vitreous body and the excised epiretinal membrane will be harvested for gas-chromatography/mass spectrometry |
Timeline
- Start date
- 2018-08-13
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2018-08-24
- Last updated
- 2020-03-10
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03646682. Inclusion in this directory is not an endorsement.